{"disease":{"id":"cvid-enteropathy","name":"cvid enteropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07284641","title":"Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Paul Szabolcs","has_results":false},{"nct_id":"NCT02199496","title":"Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03866538","title":"Budesonide in Patients With Immune Mediated Enteropathies","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Mayo Clinic","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}